Journals / Eurasian Journal of Emergency Medicine / 2016 / Cilt: 15 - Sayı: 2

Evaluation of Gastrointestinal System Findings in Crimean-Congo Hemorrhagic Fever Patients

Pages
105–107
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Considering that early diagnosis is vital for the clinical course of the patients and the prevention of hospital infections and that every patient may not have a history of tick bite, it should be kept in mind that the disease can occur particularly with GIS findings in high season living in endemic regions and thus CCHF should be suspected.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Crimean-Congo hemorrhagic fever (CCHF) is a disease caused by a virus.
📊
Key Findings & Data:Enzyme-linked immunosorbent assay and/or Polymerase Chain Reaction tests were used for diagnoses.Results: The ratio of tick bite history was found to be 73.1%.
💡
Conclusion & Impact:Conclusion: Considering that early diagnosis is vital for the clinical course of the patients and the prevention of hospital infections and that every patient may not have a history of tick bite, it should be kept in mind that the disease can occur particularly with GIS findings in high season living in endemic regions and thus CCHF should be suspected.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Crimean-Congo hemorrhagic fever (CCHF) is a disease caused by a virus. Early diagnosis of CCHF particularly in regions where the disease frequently occurs is important for taking necessary measures and for immediately starting the treatment process. This study aims to evaluate gastrointestinal system (GIS) findings in the patients. Materials and Methods: Patient history, such as nausea, vomiting, abdominal pain, diarrhea, values of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, and contact with tick, was recorded. Enzyme-linked immunosorbent assay and/or Polymerase Chain Reaction tests were used for diagnoses.Results: The ratio of tick bite history was found to be 73.1%. According to the GIS findings of the patients at the time of admission, the ratio of nausea and vomiting, abdominal pain, diarrhea, and elevated AST and ALT levels were 61.2%, 37.6%, 27.9%, and 78.4% respectively. Five of the 93 patients died, and the mortality rate was 5.4%. Conclusion: Considering that early diagnosis is vital for the clinical course of the patients and the prevention of hospital infections and that every patient may not have a history of tick bite, it should be kept in mind that the disease can occur particularly with GIS findings in high season living in endemic regions and thus CCHF should be suspected.

🔖

Cite This Article

DOĞAN, S., KALAFAT, U. M., BAŞTÜRK, M., OCAK, T., İNCİ, A. (2022). Evaluation of Gastrointestinal System Findings in Crimean-Congo Hemorrhagic Fever Patients. Eurasian Journal of Emergency Medicine, Cilt: 15 - Sayı: 2, 105–107. https://ajindex.com/articles/508137

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Yilmaz GR, Buzgan T, Cevik MA, Safran A, Uzun R, Cevik MA, et al. The Evaluation of Knowledge of the Health-Care Personnel Regarding Crimean-Congo Haemorrhagic Fever. Flora J 2009; 4: 27-35
  2. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6: 203-14. [CrossRef] 3. Kaygusuz S. Preliminary Study Indicating the Epidemiological Situation of the Ticks in Kırıkkale-Kızılırmak Basın. Kırıkkale Uni J 2008; 10: 1-4
  3. Ergonul O. Crimean 5. Uyar Y, Carhan A, Albayrak N, Altaş AB. Evalution of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey. Microbiology J 2010; 44: 57-64
  4. Ozkurt Z. Crimean-Congo haemorrhagic fever. Intensive Care J 2007; 7: 85-90
  5. Duru F, Fisgin T. Hematological aspects of Crimean-Congo hemorrhagic fever. Turk J Hematol 2009; 26: 161-6
  6. Gonen I. Clinical and laboratory findings of patients with Crimean-Congo hemorrhagic fever in the emergency department at hospital admission. JMID 2011; 1: 1-4. [CrossRef] 9. Ozturk DB, Kuscu F, Gurbuz Y, Gül S, Tütüncü EE, Şencan İ. Evaulation of 20 CCHF cases during 2006-2007 years. Klimik J 2008; 21: 93-6
  7. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004; 10: 1379- 84. [CrossRef] 11. Ertugrul B, Uyar Y, Yavas K, et al: An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey International Journal of Infectious Diseases 2009;13:431-436
  8. Ertugrul B, Uyar Y, Yavas K, Turan C, Oncu S, Saylak O, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12: 374-9. [CrossRef] 13. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005; 54: 385-9. [CrossRef] 14. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006; 12: 551-4. [CrossRef] 15. Midilli K, Gargili A, Ergonul O, Sengöz G, Ozturk R, Bakar M, et al. Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis 2007; 7: 54. [CrossRef] 16. Ergönül O, Celikbaş A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a